# Kinomatic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kinomatic

- Industry: Healthcare
- Headquarters: US
- Website: www.kinomatic.com
- Total disclosed funding: $4M
- Latest round: Seed (Jun 18, 2026)
- Investors on record: 1

## About

Based in the US, Kinomatic LLC specializes in AI-driven software that enhances custom surgical planning for joint replacements, particularly knee and hip procedures, improving surgical efficiency and patient outcomes.

Founded in the United States in 2021, Kinomatic LLC develops advanced software solutions for orthopedic surgical planning. In June 2026, the company secured USD 4.00 mn in SEED funding led by Waterline Ventures, bringing total funding to USD 4.00 mn. Since its inception, the company has completed 1 deal.

Kinomatic develops AI-powered segmentation software for creating custom surgical plans for joint replacement procedures, with a primary focus on knee and hip surgeries. Its flagship product helps surgeons build highly realistic 3D models of a patient’s anatomy, supporting biomechanical simulations and detailed templating. By accounting for each patient’s unique anatomical differences, the technology helps optimize implant balancing and improve long-term outcomes. Kinomatic works with orthopedic surgeons and medical facilities that need accurate surgical planning tools. The company mainly operates in the United States and is expanding globally, with a focus on regions that have advanced healthcare systems and a strong interest in innovative surgical solutions.

Kinomatic earns revenue by working with healthcare institutions and directly with orthopedic surgeons, rather than through a direct-to-consumer model. Its services are usually provided under contractual agreements with medical facilities, and surgeons rely on Kinomatic's software to support and enhance their procedures. The company charges for end-to-end surgical planning services that involve extensive preparation and patient-specific modeling tailored to each individual’s needs. Since these services can be built into existing surgical workflows, they create meaningful value for both the surgical experience and the outcomes. Kinomatic™ Custom Surgical Planning is the company’s flagship technology and the basis of its revenue-generating activities, providing a differentiated solution in the orthopedic surgery market.

In June 2026, Kinomatic LLC secured USD 4.00 mn in seed funding, led by Waterline Ventures. The company plans to use the funding to scale operations by hiring new talent and opening a new office. It also aims to further develop its AI-enabled surgical planning platform to improve long-term opioid-sparing surgical outcomes and patient recovery experiences. In addition, Kinomatic is seeking to expand into more global markets, with a focus on regions that have advanced healthcare systems and are open to innovative surgical solutions.

## Funding rounds

- Seed, Jun 18, 2026, $4M — Waterline Ventures

## Investors

- Waterline Ventures (https://capitalatlas.ai/funds/waterline-ventures) — Seed